Minimally Invasive Mitral Valve Repair and UK Mini-Mitral Trial: How Does This Change Clinical Practice?
Minimally invasive mitral valve repair for degenerative mitral regurgitation has become increasingly popular. Several observational studies have suggested it is safe and effective, with outcomes comparable to traditional open-heart surgery. For the first time, a randomized, controlled trial has now compared the two approaches to surgical mitral valve repair.
Patients with degenerative mitral regurgitation are best treated with surgical mitral valve repair, but less invasive interventions such as transcatheter edge to edge repair have caught the attention of both patients and cardiologists. The UK Mini Mitral Trial randomized patients to either full sternotomy or mini-thoracotomy approach to mitral valve repair surgery, assessing the benefits of a less invasive approach to mitral regurgitation. These results were presented at the ACC.23 Scientific Sessions and implications of the trial will be discussed on this ACC webinar.
Key Objectives/Learning Outcomes: For the first time, a randomized, controlled trial has now compared the two approaches to surgical mitral valve repair.
S. Chris Malaisrie, MD, FACC Moderator, Chair ACC Cardiac Surgery Team Council
Moritz C. Wyler von Ballmoos, MD, PhD, MPH, FACC, Moderator, ACC Cardiac Surgery Team Council Member
Enoch Francis Akowuah, MD, MRCS, MBChB, Speaker PI and 1st author of UK Mini Mitral Trial
Joanna Chikwe, MD, FACC, Panelist, Editor in Chief, Annals of Thoracic Surgery
Wayne Batchelor, MD, MHS, FACC, Chair ACC Interventional Council
No credit is being offered for this webinar.
Clinical Topics: Cardiac Surgery